Compare Enbridge Inc (ENB) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Smith & Nephew plc — how do they compare? Enbridge Inc trades at $46.6 (market cap $103.38B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: Enbridge Inc is far larger — about 9.3× Smith & Nephew plc's market cap, and Enbridge Inc pays the higher dividend (6.02%). Which is the better fit depends on your goals — on Pluang, investors hold Enbridge Inc for 91 Days and Smith & Nephew plc for 121 Days on average.
| ENB | SNN | |
|---|---|---|
Market Cap | $103.38B | $11.10B |
Volume | 3,684,305 | 1,051,703 |
Sector | Energy | Health |
52-Week High | $58.04 | $37.17 |
52-Week Low | $45.23 | $26.42 |
Typical Hold Time | 91 Days | 121 Days |
Enterprise Value | $185.39B | $14.13B |
Dividend Yield | 6.02% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENB trades at $46.6, up 1.55% today, with a bearish technical signal but strong fundamental performance. The company reported revenue of $65.19B in 2025, with net income of $7.49B, and has beaten earnings estimates in recent quarters. Analyst consensus is mixed with a $61.63 price target, while recent news highlights its 6% dividend yield and growth in midstream and renewable energy assets.
Outlook remains balanced; ENB offers a stable dividend and EBITDA growth but faces headwinds from rising interest rates and high debt levels. Investment appeal hinges on execution of its $41B project backlog and ability to navigate energy market volatility, with risks including oil price fluctuations and leverage concerns.
SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.
The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
